HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells.

Abstract
Pyruvate dehydrogenase kinase (PDK) is a pivotal enzyme in cellular energy metabolism that has previously been implicated in cancer through both RNAi based studies and clinical correlations with poor prognosis in several cancer types. Here, we report the discovery of a novel and selective ATP competitive pan-isoform inhibitor of PDK, VER-246608. Consistent with a PDK mediated MOA, VER-246608 increased pyruvate dehydrogenase complex (PDC) activity, oxygen consumption and attenuated glycolytic activity. However, these effects were only observed under D-glucose-depleted conditions and required almost complete ablation of PDC E1α subunit phosphorylation. VER-246608 was weakly anti-proliferative to cancer cells in standard culture media; however, depletion of either serum or combined D-glucose/L-glutamine resulted in enhanced cellular potency. Furthermore, this condition-selective cytostatic effect correlated with reduced intracellular pyruvate levels and an attenuated compensatory response involving deamination of L-alanine. In addition, VER-246608 was found to potentiate the activity of doxorubicin. In contrast, the lipoamide site inhibitor, Nov3r, demonstrated sub-maximal inhibition of PDK activity and no evidence of cellular activity. These studies suggest that PDK inhibition may be effective under the nutrient-depleted conditions found in the tumour microenvironment and that combination treatments should be explored to reveal the full potential of this therapeutic strategy.
AuthorsJonathan D Moore, Anna Staniszewska, Terence Shaw, Jalanie D'Alessandro, Ben Davis, Alan Surgenor, Lisa Baker, Natalia Matassova, James Murray, Alba Macias, Paul Brough, Mike Wood, Patrick C Mahon
JournalOncotarget (Oncotarget) Vol. 5 Issue 24 Pg. 12862-76 (Dec 30 2014) ISSN: 1949-2553 [Electronic] United States
PMID25404640 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • Enzyme Inhibitors
  • Isoenzymes
  • Pyrimidines
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • VER-246608
  • Adenosine Triphosphate
  • Protein Serine-Threonine Kinases
Topics
  • Adenosine Triphosphate (metabolism)
  • Benzamides (pharmacology)
  • Binding, Competitive
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Glycolysis (drug effects)
  • Humans
  • Isoenzymes
  • K562 Cells
  • Models, Molecular
  • Molecular Structure
  • Neoplasm Invasiveness
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Pyrimidines (pharmacology)
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: